ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 229 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 2.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $22,000 | +57.1% | 247 | +1.6% | 0.00% | – |
Q3 2021 | $14,000 | +1300.0% | 243 | +2109.1% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 11 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 11 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | 0.0% | 11 | 0.0% | 0.00% | – |
Q3 2020 | $1,000 | -75.0% | 11 | -82.5% | 0.00% | – |
Q2 2020 | $4,000 | +33.3% | 63 | -3.1% | 0.00% | – |
Q1 2020 | $3,000 | -76.9% | 65 | -79.6% | 0.00% | – |
Q4 2019 | $13,000 | -99.1% | 318 | -99.0% | 0.00% | -100.0% |
Q3 2019 | $1,523,000 | +50666.7% | 33,257 | +41997.5% | 0.00% | – |
Q1 2019 | $3,000 | +50.0% | 79 | +58.0% | 0.00% | – |
Q4 2018 | $2,000 | 0.0% | 50 | -5.7% | 0.00% | – |
Q3 2018 | $2,000 | -80.0% | 53 | -76.7% | 0.00% | – |
Q2 2018 | $10,000 | -97.5% | 227 | -97.7% | 0.00% | – |
Q1 2018 | $393,000 | +4.5% | 9,956 | -10.0% | 0.00% | – |
Q4 2017 | $376,000 | -41.0% | 11,060 | -55.7% | 0.00% | -100.0% |
Q3 2017 | $637,000 | +15825.0% | 24,944 | +12372.0% | 0.00% | – |
Q2 2017 | $4,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |